First Time Loading...

3SBio Inc
HKEX:1530

Watchlist Manager
3SBio Inc Logo
3SBio Inc
HKEX:1530
Watchlist
Price: 6.8 HKD 3.34% Market Closed
Updated: May 5, 2024

3SBio Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

3SBio Inc
Net Income (Common) Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
3SBio Inc
HKEX:1530
Net Income (Common)
¥1.5B
CAGR 3-Years
23%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Net Income (Common)
-¥13.6B
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Net Income (Common)
-¥1B
CAGR 3-Years
-1%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Net Income (Common)
¥1.2B
CAGR 3-Years
23%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Net Income (Common)
¥8.5B
CAGR 3-Years
40%
CAGR 5-Years
47%
CAGR 10-Years
45%
Imeik Technology Development Co Ltd
SZSE:300896
Net Income (Common)
¥1.3B
CAGR 3-Years
61%
CAGR 5-Years
73%
CAGR 10-Years
N/A

See Also

What is 3SBio Inc's Net Income (Common)?
Net Income (Common)
1.5B CNY

Based on the financial report for Dec 31, 2023, 3SBio Inc's Net Income (Common) amounts to 1.5B CNY.

What is 3SBio Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
4%

Over the last year, the Net Income (Common) growth was -19%. The average annual Net Income (Common) growth rates for 3SBio Inc have been 23% over the past three years , 4% over the past five years .